Global Innovative Platforms Inc. (GIPL) stock
Close on Oct 19, 2026Market cap –P/E –Yield –
Global Innovative Platforms Inc. reported revenue of $30.00K for the twelve months to Dec 31, 2025.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $30.00K
- Net income
- -$647.21K
- EPS, diluted
- -$0.02
Trading
- Previous close
- $0.50
- Open
- $0.50
- Day's range
- $0.50 – $0.50
- Volume
- 0
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | GIPL | S&P 500 | Difference | GIPL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | +0.0% | +3.4% | −3.4 pts | ||
| Year to date | +350.5% | +13.3% | +337.2 pts | ||
| 1 year | +222.4% | +16.6% | +205.8 pts | ||
| 3 years | -52.4% | +86.4% | −138.8 pts | -21.9% | +23.1% |
| 5 years | -89.7% | +81.9% | −171.6 pts | -36.5% | +12.7% |
| 10 years | -80.8% | +318.9% | −399.6 pts | -15.2% | +15.4% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Press releases
Releases Global Innovative Platforms filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
About Global Innovative Platforms
Surgical & Medical Instruments & Apparatus
Global Innovative Platforms Inc. is a medical technology company developing non-invasive diagnostic tools that use breath analysis and air quality monitoring to detect animal diseases and assess treatment effectiveness. Its primary focus is creating a canine breath test to identify heartworm infections across early and mature stages, with additional capabilities to monitor therapy response and detect conditions across other animals and agriculture. The company utilizes proprietary gas chromatography devices, specifically the VOCAM Plus and FROG, paired with cloud-based artificial intelligence software to rapidly analyze volatile organic compound patterns without requiring blood samples or needle sticks.
Company profile, executives and historyGlobal Innovative Platforms stock: common questions
What is Global Innovative Platforms's stock price?
GIPL closed at $0.50 on Oct 19, 2026, up 0.00% on the day.
What is GIPL's P/E ratio?
Global Innovative Platforms lost money over the twelve months to Dec 31, 2025 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does Global Innovative Platforms make?
Global Innovative Platforms reported revenue of $30.00K for the twelve months to Dec 31, 2025.
Does Global Innovative Platforms pay a dividend?
No. Global Innovative Platforms has not paid a cash dividend over the last twelve months.
How has GIPL stock performed over the past year?
Including dividends, GIPL returned +222.4% over the past year, against +16.6% for the S&P 500.
Who are Global Innovative Platforms's competitors?
Companies most similar to Global Innovative Platforms by business, industry and size include RDGL, PFSA, PAVM, GUTS, QTEX.
See a number that looks wrong?